The Treatment of Depression With Botulinum Type A Toxin

Completed · Phase 2 · Has a placebo group

Conditions studied: Depression

In brief

A 24-week Randomized, Double-blind study treating people who suffer from depression who also have moderate to severe frown lines in forehead region with Botox injections. Subjects participating will have their photos taken and complete a questionnaire regarding their depression. They will see a psychiatrist at every visit who will assess their depression.

Key facts

Study ID
NCT01392963
Run by
Seton Healthcare Family
People needed
30
Starts
2011-07-01
Expected to finish
2013-06-01
Last updated by the study team
2018-07-26

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.